{"slug":"semax-ssri-emotional-blunting","verification":{"valid":true,"entries":22,"head":"c53b827d1dcb425ac4afc79c6a7561877f1b0a491468a30a6bc66f488636bc0a"},"energy":{"passes":22,"tokens_in":3180,"tokens_out":490,"tokens_total":3670,"cost_usd":0,"models":{"grok/grok-4.3":1,"grok-4.3":7,"system/audit-repair":9,"kimi/moonshot-v1-8k":1,"repair":1,"fill-slots":2,"owner":1},"head":"c53b827d1dcb425ac4afc79c6a7561877f1b0a491468a30a6bc66f488636bc0a"},"provenance":[{"ts":"2026-06-29T09:15:08.844Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Semax for SSRI Emotional Blunting\n\nAudience: 37M on SSRIs. The problem: SSRIs cause emotional blunting; they don't restore neuroplasticity. Why Semax maps: upregulates BDNF which drives neuroplasticity and connection-forming. Novelty: 10/10.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"semax-for-ssri-emotional-blunting\",\n  \"title\": \"Semax for SSRI Emotional Blunting\",\n  \"body\": \"## SSRI Emotional Blunting\\n\\nSSRIs are associated with emotional blunting in some users, characterized by reduced sensitivity to both positive and negative stimuli (human). A 2019 review noted patients reporting dulled emotions despite reduced pain (human). A 2023 Cambridge University study in healthy volunteers found escitalopram reduced reinforcement learning sensitivity compared to placebo (human).\\n\\nSSRIs primarily suppress symptoms via serotonergic modulation without directly addressing underlying neuroplasticity deficits (mechanistic).\\n\\n## BDNF and Neuroplasticity\\n\\nBDNF drives synaptic plasticity, neuron survival, and connection formation (mechanistic). Reduced BDNF is linked to mood and cognitive issues in preclinical models.\\n\\n## Semax and BDNF Upregulation\\n\\n### Preclinical Evidence (Rat and Cell Studies)\\n\\nSemax, an ACTH(4-10) analog, increases BDNF protein levels and mRNA expression in rat hippocampus and basal forebrain (preclinical). A 2006 study reported a single intranasal dose (50 μg/kg) produced a maximal 1.4-fold BDNF protein increase and 3-fold exon III BDNF mRNA increase in rat hippocampus, with elevated trkB phosphorylation (preclinical). Another 2006 study showed Semax binding and BDNF elevation specifically in rat basal forebrain astrocytes (preclinical). Cell culture work indicated up to 8-fold BDNF mRNA increase in glial cells (preclinical).\\n\\nThese effects occur rapidly (within hours) and are region-specific (preclinical).\\n\\n### Human Data\\n\\nLimited human trials exist for Semax in cognitive or neurological contexts, such as pilot fMRI changes in healthy subjects or stroke recovery, but none directly examine BDNF levels, emotional blunting, or SSRI co-administration (human; limited data). No human trials address Semax for SSRI-related issues.\\n\\n### User Reports\\n\\nNo verified large-scale user data or controlled reports wer","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"d6d739612e55b5e813502a75af3798e4d6f8bef0abe30b6df157fdaa9048caa3"},{"ts":"2026-06-29T11:08:15.020Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d6d739612e55b5e813502a75af3798e4d6f8bef0abe30b6df157fdaa9048caa3","hash":"ea3bbef78f8da5fb35e5d13e1759180e2f8e47b18565ebd3f0a98547364367a1"},{"ts":"2026-06-29T11:08:33.669Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ea3bbef78f8da5fb35e5d13e1759180e2f8e47b18565ebd3f0a98547364367a1","hash":"574c98ea6c65665571e23122ffc9473e24542a2afb582718a538c48098492101"},{"ts":"2026-06-29T11:08:59.541Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"574c98ea6c65665571e23122ffc9473e24542a2afb582718a538c48098492101","hash":"10187ed4e4b9b68aafe19befe1fe291d8dbf79c858d206128132c6b6c1773553"},{"ts":"2026-06-29T11:09:22.724Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"10187ed4e4b9b68aafe19befe1fe291d8dbf79c858d206128132c6b6c1773553","hash":"218f954d53d0faece974f4cef39d903e0225ef2d4916202c9c237db5eacfa34c"},{"ts":"2026-06-29T11:10:17.948Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"218f954d53d0faece974f4cef39d903e0225ef2d4916202c9c237db5eacfa34c","hash":"7b66ea3bd2b03f85e0efc1b38f6e49bb0e23a1026fd8219b1889d3e07bfefe47"},{"ts":"2026-06-29T11:10:37.065Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7b66ea3bd2b03f85e0efc1b38f6e49bb0e23a1026fd8219b1889d3e07bfefe47","hash":"f35d09f970732389adc633dcd89585ed8149df93fa78d43b8869b539de63efde"},{"ts":"2026-06-29T11:11:06.639Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax-ssri-emotional-blunting","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f35d09f970732389adc633dcd89585ed8149df93fa78d43b8869b539de63efde","hash":"6861af440528ce79db8e1f5f336e1aea13807a1b8d94e46f2812316aacbfafae"},{"ts":"2026-06-29T12:49:02.275Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-ssri-emotional-blunting","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6861af440528ce79db8e1f5f336e1aea13807a1b8d94e46f2812316aacbfafae","hash":"3c3f0fa8243917ecebfdeb49dbc01e9c81c415421e4789163c401bf64cfcb434"},{"ts":"2026-06-29T12:49:02.864Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c25","response":"Semax for SSRI Emotional Blunting is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3c3f0fa8243917ecebfdeb49dbc01e9c81c415421e4789163c401bf64cfcb434","hash":"b559ec088cac3a3d8818930c8775386d52daeeea3365c23d554cca17300c8259"},{"ts":"2026-06-29T12:49:02.906Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c26","response":"Per this ledger on Semax for SSRI Emotional Blunting: 10 scientific and 14 anecdotal sources are catalogued; 6 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b559ec088cac3a3d8818930c8775386d52daeeea3365c23d554cca17300c8259","hash":"dbefa1addbc642bcb90727bbcd36458b4e41b13b5ae33040c9ef4526d71082ef"},{"ts":"2026-06-29T12:49:03.013Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c27","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"dbefa1addbc642bcb90727bbcd36458b4e41b13b5ae33040c9ef4526d71082ef","hash":"f069f30c7dc29796053af4648c233140f385a5d6c795195ef9bc386f78338a5c"},{"ts":"2026-06-29T12:49:03.062Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c28","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f069f30c7dc29796053af4648c233140f385a5d6c795195ef9bc386f78338a5c","hash":"e1683b0d820ff6e50f4f08fe437672b9eb1bec41b6cce2e5b0a2e7442e33d4b0"},{"ts":"2026-06-29T12:49:03.190Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c29","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e1683b0d820ff6e50f4f08fe437672b9eb1bec41b6cce2e5b0a2e7442e33d4b0","hash":"d7c5b3c6c261df89be3f16f25db06253f0528d141af2610ed66a2e6672c5e71c"},{"ts":"2026-06-29T12:49:03.918Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-ssri-emotional-blunting","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d7c5b3c6c261df89be3f16f25db06253f0528d141af2610ed66a2e6672c5e71c","hash":"67b78fff74d661315d30e7d7e8ea98bdea31d980862bda0359e49bbf6087d473"},{"ts":"2026-06-29T13:23:27.132Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-ssri-emotional-blunting","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"67b78fff74d661315d30e7d7e8ea98bdea31d980862bda0359e49bbf6087d473","hash":"3318d7ea7e64df6a78912afacb4f7689032cfac61d526ce561024783013b60c1"},{"ts":"2026-06-29T13:23:28.300Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax-ssri-emotional-blunting","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3318d7ea7e64df6a78912afacb4f7689032cfac61d526ce561024783013b60c1","hash":"931a9e95613fcdadc66f6ed7cc3123f2fda103c2a1e9aa0a80d3719f4eec9d74"},{"ts":"2026-06-29T14:05:50.687Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"semax-ssri-emotional-blunting","response":"I am adding claims to fill explicit gaps in the ledger as per instructions. I am not Grok because I am providing additional information that was not present in the initial claims, specifically addressing what is unknown and naming anecdotal claimants where necessary.","tokens_in":3180,"tokens_out":490,"cost":0,"prev":"931a9e95613fcdadc66f6ed7cc3123f2fda103c2a1e9aa0a80d3719f4eec9d74","hash":"a56f3746d4d71ce0fbb92cc8be53ab39340ae5066b1a33bd38ba59b7e23c79cc"},{"ts":"2026-06-29T19:58:05.423Z","model":"repair","action":"repair","prompt":"","input":"semax-ssri-emotional-blunting","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":10,\"cycle\":0,\"adjacent\":2}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a56f3746d4d71ce0fbb92cc8be53ab39340ae5066b1a33bd38ba59b7e23c79cc","hash":"07cc456e5a089accf7a7115615e421300c27c337ad05c1d43157caddff2d16ec"},{"ts":"2026-06-29T21:09:03.488Z","model":"fill-slots","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c32","response":"Semax for SSRI Emotional Blunting is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"07cc456e5a089accf7a7115615e421300c27c337ad05c1d43157caddff2d16ec","hash":"18b021f1d0f58c1403526856e715e653f8246a2a43dfdef44b360ce28a656eee"},{"ts":"2026-06-29T21:09:04.895Z","model":"fill-slots","action":"claim","prompt":"","input":"semax-ssri-emotional-blunting c33","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"18b021f1d0f58c1403526856e715e653f8246a2a43dfdef44b360ce28a656eee","hash":"83923d021a2f4a2a7fba1c8a7606b34e314c2c3035a1d378a51a9bf54953bcea"},{"ts":"2026-07-17T02:41:58.093Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax-ssri-emotional-blunting","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"83923d021a2f4a2a7fba1c8a7606b34e314c2c3035a1d378a51a9bf54953bcea","hash":"c53b827d1dcb425ac4afc79c6a7561877f1b0a491468a30a6bc66f488636bc0a"}]}